Table 5.
Progressive enlargement of aneurysmal dilatation (n = 4) | Non-progressive aneurysmal dilatation (n = 4) | P | |
---|---|---|---|
Time to MRI from symptom onset, days | 216 (196–231) | 182.0 (157–193.5) | 0.083 |
Male | 3 (75) | 2 (50) | 1.000 |
Age, years | 48.5 (46–53.5) | 42.5 (39–50.5) | 0.245 |
Initial symptom | 0.429 | ||
Ischemic symptom | 2 (50) | 0 (0) | |
Headache | 2 (50) | 4 (100) | |
Hypertension | 2 (50) | 0 (0) | 0.429 |
Diabetes | 1 (25) | 0 (0) | 1.000 |
Hyperlipidemia | 1 (25) | 1 (25) | 1.000 |
Smoking | 1 (25) | 2 (50) | 1.000 |
Old CVA | 0 (0) | 0 (0) | |
Family history | 0 (0) | 1 (25) | 1.000 |
VW-MRI | |||
Dissecting flap | 4 (100) | 2 (50) | 0.429 |
Double lumen | 4 (100) | 1 (25) | 0.143 |
Intramural hematoma | 4 (100) | 1 (25) | 0.143 |
Increased outer diameter | 4 (100) | 4 (100) | NA |
Onion-skin appearance | 4 (100) | 0 (0) | 0.029* |
Wall enhancement | 4 (100) | 2 (50) | 0.429 |
Preserved patency | 4 (100) | 3 (75) | 1.000 |
Eccentricity index | 0.84 (0.74–0.94) | 0.54 (0.39–0.72) | 0.059 |
Remodeling index | 16.56 (7.80–24.71) | 2.39 (2.11–2.97) | 0.021* |
Normalized wall index | 0.98 (0.96–0.99) | 0.67 (0.65–0.76) | 0.021* |
rsIMH | 4.60 (3.21–4.92) | 1.38 (1.24–1.46) | 0.021* |
TOF-MRA | |||
Dissecting flap | 4 (100) | 2 (50) | 0.429 |
Double lumen | 4 (100) | 1 (25) | 0.143 |
Intramural hematoma | 4 (100) | 0 (0) | 0.029* |
Increased outer diameter | 3 (75) | 3 (75) | 1.000 |
Preserved patency | 3 (75) | 3 (75) | 1.000 |
Remodeling index | 12.96 (7.47–19.2) | 2.02 (1.66–2.89) | 0.021* |
rsIMH | 2.67 (1.91–3.28) | 1.07 (0.96–2.16) | 0.149 |
Data are expressed as the number of cases with percentages in parentheses or median (interquartile range). VW-MRI vessel wall magnetic resonance image; TOF-MRA time of flight-magnetic resonance angiography; CVA cerebrovascular accident; rsIMH relative signal intensity of intramural hematoma. * indicates statistical significance (P < 0.05).